Next-gen obesity drug helps patients lose 28% of body weight: Eli Lilly
Eli Lilly can now seek regulatory approval and potentially launch the next-generation drug in 2027.
Original Source
Read the full article at Newsnationnow →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.